Skip to main content
. 2020 Oct 7;61:103053. doi: 10.1016/j.ebiom.2020.103053

Fig. 2.

Fig 2:

TBAg1 and TBAg2 responses. A) TBAg1a and B) TBAg2b IGRAc results of the six participants who converted during visit 2 (follow up enrolment) and reverted after 3 days (review enrolment). Each of the six participants had TSTd readings of 0 mm.The threshold of 0·35 IU/ml is indicated by the dashed line.

aTBAg1 (TB1 tube result for QuantiFERON®-TB Gold Plus test)

bTBAg2 (TB2 tube result for QuantiFERON®-TB Gold Plus test)

cIGRA (interferon gamma release assay)

dTST (tuberculin skin test)